RBC Capital raised the firm’s price target on Rayonier Advanced Materials to $10 from $9 and keeps an Outperform rating on the shares. Following its metings with the company management, the firm has come away with a positive view of Rayonier’s progress on refinancing its 2026 notes and its Biomaterials strategy, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAM: